Why the study?
Angiosarcoma of bone is a rare malignant vascular tumor, and this study aimed to report on its treatments and prognosis.
Population
80 patients with angiosarcoma of bone across 9 centers
Design
Multicenter retrospective study
Follow-up
Median 31 months
Authors
Loading...
Multicenter B-AS data inform current multimodal approaches; leaves open optimal strategies pending prospective trials.
Patients with metastatic angiosarcoma of bone have a dismal prognosis, though surgical complete remission and adjuvant radiotherapy may improve outcomes in localized disease.
Palmerini et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: